Back

Influence of AF burden on NT-proBNP and left ventricular reverse remodeling in patients with AF and HF: catheter ablation versus pharmacological rhythm control

29 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: metabolic and mechanistic insights Rhythm Control, Catheter Ablation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mrs Bagul Orazlyyeva

Ashgabat (Turkmenistan)

6 More presentations in this session

Presentation thumbnail
Sex-specific FIND-AF risk thresholds aligned with CMR-defined atrial cardiomyopathy identify excess cardiovascular risk in heart failure across nationwide primary care data
Doctor K. Kazi (Manchester, GB)
Abstract
Presentation thumbnail
Gut microbiota-derived isovaleric acid alleviates atrial fibrillation by suppressing GSDME-dependent pyroptosis
Doctor N. Ding (Xi'an, CN)
Abstract
Presentation thumbnail
Metabolic improvement without structural reverse remodelling in diabetic atrial fibrillation patients receiving lifestyle modification: A post-hoc analysis of the PRAGUE-25 trial
Doctor J. Mohr (Trinec, CZ)
Abstract
Presentation thumbnail
Symptoms and quality of life in individuals with screen-detected atrial fibrillation: insights from the NORSCREEN trial
Mr M. Boskovic (Kristiansand, NO)
Abstract
Presentation thumbnail
Association of diabetes, glycemic status and vascular brain lesions in patients with atrial fibrillation
Ms S. Balasundaram (Basel, CH)
Abstract

Access the full session

Session thumbnail
Atrial fibrillation: metabolic and mechanistic insights

The Event

Event poster

ESC Congress 2026

29 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Long-term heart failure improvement after catheter ablation of persistent atrial fibrillation in heart failure with preserved, mildly reduced and reduced ejection fraction
30 March 2025
thumbnail
Congress Presentation
Clinical effects and safety of NT-proBNP-guided therapy in patients hospitalized for acute decompensated heart failure.
29 June 2021
thumbnail
Congress Presentation
Colchicine and af burden reduction in nonpermanent atrial fibrillation
4 April 2025
thumbnail
Congress Presentation
Cardiac resynchronization therapy alters left ventricular myocardial gene expression profile in patients with end-stage dilated cardiomyopathy
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources